Drug Patents owned by Upsher Smith Labs

1. Drug name - QUDEXY XR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8652527 UPSHER SMITH LABS Extended-release topiramate capsules Mar, 2033

(10 years from now)

US10363224 UPSHER SMITH LABS Extended-release topiramate capsules Mar, 2033

(10 years from now)

US8889190 UPSHER SMITH LABS Extended-release topiramate capsules Mar, 2033

(10 years from now)

US9101545 UPSHER SMITH LABS Extended-release topiramate capsules Mar, 2033

(10 years from now)

US9555005 UPSHER SMITH LABS Extended-release topiramate capsules Mar, 2033

(10 years from now)

Drugs and Companies using TOPIRAMATE ingredient

Treatment: Treatment of seizures

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
25MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
150MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

2. Drug name - TOSYMRA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8268791 UPSHER SMITH LABS Alkylglycoside compositions for drug administration May, 2026

(3 years from now)

US8440631 UPSHER SMITH LABS Compositions for drug administration May, 2026

(3 years from now)

US9283280 UPSHER SMITH LABS Compositions for drug administration May, 2026

(3 years from now)

US9610280 UPSHER SMITH LABS Formulations comprising triptan compounds Jun, 2030

(7 years from now)

US10603305 UPSHER SMITH LABS Formulations comprising triptan compounds Jun, 2030

(7 years from now)

US9974770 UPSHER SMITH LABS Formulations comprising triptan compounds Jun, 2030

(7 years from now)

US9211282 UPSHER SMITH LABS Formulations comprising triptan compounds Jul, 2031

(8 years from now)

Drugs and Companies using SUMATRIPTAN ingredient

Treatment: Acute treatment of migraine

Dosage: SPRAY;NASAL

More Information on Dosage
Strength Dosage Availability
10MG/SPRAY SPRAY;NASAL Prescription

3. Drug name - VOGELXO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9295675 UPSHER SMITH LABS Testosterone gel compositions and related methods Feb, 2034

(11 years from now)

US9662340 UPSHER SMITH LABS Testosterone gel compositions and related methods Feb, 2034

(11 years from now)

US8785426 UPSHER SMITH LABS Testosterone gel compositions and related methods Feb, 2034

(11 years from now)

Drugs and Companies using TESTOSTERONE ingredient

Treatment: Method for transdermal delivery of testosterone

Dosage: GEL, METERED;TRANSDERMAL; GEL;TRANSDERMAL

More Information on Dosage
Strength Dosage Availability
12.5MG/1.25GM ACTUATION GEL, METERED;TRANSDERMAL Prescription
50MG/5GM PACKET GEL;TRANSDERMAL Prescription

4. Drug name - ZEMBRACE SYMTOUCH

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10537554 UPSHER SMITH LABS Pharmaceutical composition for treating migraine Jan, 2036

(13 years from now)

Drugs and Companies using SUMATRIPTAN SUCCINATE ingredient

Treatment: Treatment of migraine

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML) SOLUTION;SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.